COMPANY PROFILE · UPDATED 18 NOV 2025
Areteia Therapeutics
Areteia Therapeutics is a new biotechnology company committed to putting asthma patients in better control of their disease—and back in control of their lives—with the first potential oral drug for eosinophilic asthma.
This profile is unclaimed — do you work here? Claim it
Claim it →- Founded
- 2022
- Headcount
- 27
- Open roles
- 0
- Last raised
- Series A · Sign in to view
LEADERSHIP
Founders & key people
OPEN ROLES
Roles at Areteia Therapeutics
Employbl doesn’t track Areteia Therapeutics’s job board yet, so there’s nothing to show here — they may still be hiring. You can also search all jobs →
FUNDING
Capital raised
TAGS
Categorized in
Investors
LOCATIONS
Where they work
Areteia Therapeutics offices
Loading map…
- Chapel Hill, NC101 Glen Lennox Dr suite 300